Genetic Determinants of Amitriptyline Efficiency for Pain Treatment

PHASE4CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

May 31, 2018

Study Completion Date

January 31, 2019

Conditions
Chronic Pain
Interventions
DRUG

Amitriptyline

100 mg single dose

DRUG

Tolterodine

Placebo 1 mg single dose

Trial Locations (1)

3010

Dep. of Anesthesiology, Bern University Hospital, Bern

All Listed Sponsors
collaborator

University of Washington

OTHER

collaborator

Ludwig-Maximilians - University of Munich

OTHER

collaborator

Aalborg University

OTHER

lead

Insel Gruppe AG, University Hospital Bern

OTHER

NCT02256943 - Genetic Determinants of Amitriptyline Efficiency for Pain Treatment | Biotech Hunter | Biotech Hunter